Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nonmercaptalbumin as an oxidative stress marker in Parkinson's and PARK2 disease.
Ueno SI, Hatano T, Okuzumi A, Saiki S, Oji Y, Mori A, Koinuma T, Fujimaki M, Takeshige-Amano H, Kondo A, Yoshikawa N, Nojiri T, Kurano M, Yasukawa K, Yatomi Y, Ikeda H, Hattori N. Ueno SI, et al. Among authors: mori a. Ann Clin Transl Neurol. 2020 Mar;7(3):307-317. doi: 10.1002/acn3.50990. Epub 2020 Feb 14. Ann Clin Transl Neurol. 2020. PMID: 32059082 Free PMC article.
Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease.
Fujimaki M, Saiki S, Li Y, Kaga N, Taka H, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Koinuma T, Ueno SI, Imamichi Y, Ueno T, Miura Y, Funayama M, Hattori N. Fujimaki M, et al. Among authors: mori a. Neurology. 2018 Jan 30;90(5):e404-e411. doi: 10.1212/WNL.0000000000004888. Epub 2018 Jan 3. Neurology. 2018. PMID: 29298852 Free PMC article.
Metabolomics-based identification of metabolic alterations in PARK2.
Okuzumi A, Hatano T, Ueno SI, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa KI, Fujimaki M, Sato S, Ramamoorthy S, Mohney RP, Hattori N. Okuzumi A, et al. Among authors: mori a. Ann Clin Transl Neurol. 2019 Feb 21;6(3):525-536. doi: 10.1002/acn3.724. eCollection 2019 Mar. Ann Clin Transl Neurol. 2019. PMID: 30911576 Free PMC article.
A metabolic profile of polyamines in parkinson disease: A promising biomarker.
Saiki S, Sasazawa Y, Fujimaki M, Kamagata K, Kaga N, Taka H, Li Y, Souma S, Hatano T, Imamichi Y, Furuya N, Mori A, Oji Y, Ueno SI, Nojiri S, Miura Y, Ueno T, Funayama M, Aoki S, Hattori N. Saiki S, et al. Among authors: mori a. Ann Neurol. 2019 Aug;86(2):251-263. doi: 10.1002/ana.25516. Epub 2019 Jul 1. Ann Neurol. 2019. PMID: 31155745 Free PMC article.
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.
Takeshige-Amano H, Saiki S, Fujimaki M, Ueno SI, Li Y, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Tsunemi T, Daida K, Ishiguro Y, Imamichi Y, Nanmo H, Nojiri S, Funayama M, Hattori N. Takeshige-Amano H, et al. Among authors: mori a. Mov Disord. 2020 Aug;35(8):1438-1447. doi: 10.1002/mds.28068. Epub 2020 May 1. Mov Disord. 2020. PMID: 32357260 Free PMC article.
2,564 results